IQVIA Archives - Page 6 of 7 -

This year’s eyeforpharma conference in Barcelona outlined how 2018 could be a turning point for the industry. As

Could digital technology revolutionise pharma in 2018?

https://pharmaphorum.com/views-and-analysis/digital-technology-revolutionise-pharma-2018/

Insights/ Market Access/ Pharma Market Access/ Quintiles - Oncol articles/ White Papers/ Whitepapers

Standing on the cusp of something great: How real-world data is poised to transform cancer care

Adam Jeffery cancer, Drug regulation, IQVIA, Oncology, patient data, pharma, Real World Evidence 0 Comment

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care How can real world evidence (RWE) improve the

Standing on the cusp of something great: How real-world data is poised to transform cancer care

https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/

Cancer/ Oncology/ Quintiles - Oncol articles/ Views & Analysis/ Views and analysis

ASH 2017: CAR-T therapy and beyond

Richard Staines American Society of Hematology (ASH) Annual Meeting, ASH17, blood cancer, cancer, CAR T, immunooncology, IQVIA 0 Comment

As the American Society of Hematology’s 2017 congress approaches, there’s plenty to be excited about – not just

ASH 2017: CAR-T therapy and beyond

https://pharmaphorum.com/views-analysis-oncology/ash-2017-car-t-therapy-beyond/

Oncology/ Partner content/ Partner Content/ Press releases/ Quintiles-oncol-PC

When science and biology combine – the outlook for ADCs in cancer drug development

Adam Jeffery adc, antibody, cancer, combination therapies, haemato-oncology, Haematology, IQVIA, Oncology 0 Comment

Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents. Although just

When science and biology combine – the outlook for ADCs in cancer drug development

https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/

Oncology/ Partner content/ Partner Content/ Press releases/ Quintiles - ContentIO/ R&D

Top 5 challenges of immuno-oncology clinical trials

Julia Marsteller cancer, clinical trials, immunotherapy, IQVIA, pharma, quintilesIMS

Learn innovative solutions to address these challenges

Top 5 challenges of immuno-oncology clinical trials

https://pharmaphorum.com/partner-content-oncology/top-5-challenges-of-immunooncology-clinical-trials/

Cancer/ Clinical/ Oncology/ Partner Content/ Press releases/ Quintiles-oncol-PC

Oncology – the current landscape and what it means for the future

Adam Jeffery cancer, forecast, global, insight, institute, IQVIA, Oncology, quintilesIMS, Spotlight 0 Comment

The WHO reports that in 2015, cancer was the second highest cause of death globally – responsible for

Oncology – the current landscape and what it means for the future

https://pharmaphorum.com/partner-content-oncology/oncology-current-landscape-means-future/

IQVIA_infographic_section_NEW_18_11_2017 1

Partner content/ Quintiles-oncol-PC

What oncologists need from you when launching a new therapy

Adam Jeffery clinical trials, Doctors, infographic, IQVIA, Oncology, pharma 0 Comment

At the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is

What oncologists need from you when launching a new therapy

https://pharmaphorum.com/partner-content/oncologists-need-launching-new-therapy/

Oncology/ Partner content/ Partner Content/ Press releases/ Quintiles - ContentIO

How RACE legislation is changing the face of pediatric oncology in the US

Adam Jeffery cancer, clinical trials, IQVIA, legislation, Oncology, paediatric, quintilesIMS, US 0 Comment

On August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity

How RACE legislation is changing the face of pediatric oncology in the US

https://pharmaphorum.com/partner-content-oncology/race-legislation-changing-face-pediatric-oncology-us/

Debates/ Debates & Insight/ Digital and Social Media/ Sales and Marketing/ Webinars/ Webinars in home page/ Webinars On demand

11/23/2017

The evolution of pharma social media intelligence

mike.hammerton@pharmaphorum.com Digital / Social media, IQVIA, marketing, quintilesIMS 0 Comment

Is your company a fully mature user of intelligence from social media, or is it still not tapping

The evolution of pharma social media intelligence

https://pharmaphorum.com/debates-insight-sales-marketing/evolution-pharma-social-media-intelligence/

Trending

IQVIA

Login